| abstract |
(57) [Summary]nThe present invention provides therapeutics useful for inhibiting platelet aggregation, inhibiting the formation of thrombotic occlusion, and treating, preventing and reducing the risk of developing cardiovascular, cerebrovascular, and related vaso-occlusive diseases. It includes combination treatments and pharmaceutical formulations comprising an effective amount of a combination of a cholesterol-lowering agent such as an HMG-CoA reductase inhibitor and a platelet aggregation inhibitor. |